IMIPENEM-CILASTATIN Mepha 500/500mg 10 pce
7680602620023
CH-60262
J01DH51
08.01.93
1 / 3
google
Details
- Product number
- 6026201
- CPT
- -
- Packaging group
- 10
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio sicca: imipenemum anhydricum 500 mg ut imipenemum monohydricum, cilastatinum 500 mg ut cilastatinum natricum, natrii hydrogenocarbonas, pro vitro corresp. natrium 37.52 mg.
Articles (1)
Imipenem-Cilastatin-Mepha i.v., Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
10
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRS
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRS
|
- | Substance | WIZUS |
|
PRS
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRS
|
- | Substance | WIZUS |
|
PRS
|
- | Substance | HNIDK |
|
PRS
|
37.52 MG | Substance | HBESI |
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 60262
- Drug name
- Imipenem-Cilastatin-Mepha i.v., Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- PULPI
- ATC Code
- J01DH51
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 24/06/2010
- Authorization expiration date
- 31/12/9999
- IT number
- 08.01.93
- Domain
- Human medicine
Packaging details
- Description (FR)
- IMIPENEM-CILASTATIN Mepha 500/500mg 10 pce
- Description (DE)
- IMIPENEM-CILASTATIN Mepha 500/500mg 10 Stk
- Market launch
- 24/06/2010
- Narcotic (BTM)
- No